U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorization

Deutschland Nachrichten Nachrichten

U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorization
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

A panel of independent experts to the U.S. health regulator will decide on the nature of clinical trials that coronavirus vaccines should go through after receiving U.S. emergency use authorization.

The panel will also deliberate whether during such trials, volunteers should continue to receive placebo - usually a mixture of salt and water - documents posted on the regulator's website showed on Wednesday.

The U.S. Food and Drug Administration’s experts will also discuss on Thursday the criteria for allowing emergency use of a COVID-19 vaccine and plans to monitor its safety after a regulatory go-ahead. “Emergency use authorization will be granted to a vaccine that shows a very good safety profile and efficacy at or around 60% better than placebo, but I don’t think the vaccine trials right now are being run very scientifically,” said Jared Holz, healthcare strategist for brokerage Jefferies.

“Tomorrow’s meeting will serve as a barometer of what the agency will be looking at once clinical trial data is available.”The U.S. government’s efforts to speed development of a COVID-19 vaccine has led to concerns of political interference in the regulatory process at the expense of safety. The recommendations of the committee will inform the FDA’s decision around approval of a vaccine, although the agency is not required to follow the panel’s advise.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Mainland China reports 19 new COVID-19 casesMainland China reports 19 new COVID-19 casesChina reported 19 new coronavirus cases in the mainland for Oct. 19, up from 13 cases a day earlier, the health commission said on Tuesday.
Weiterlesen »

Newsom says California will review FDA-approved COVID-19 vaccines before releasing them to publicNewsom says California will review FDA-approved COVID-19 vaccines before releasing them to publicGov. Newsom added to concerns about COVID-19 vaccines and said the state will review the safety of any vaccine approved by the Trump administration.
Weiterlesen »

AstraZeneca close to restarting Covid-19 vaccine trial in U.S.AstraZeneca close to restarting Covid-19 vaccine trial in U.S.AstraZeneca is likely to restart its late-stage U.S. coronavirus vaccine trial 'very soon,' possibly later this week, according to one of the researchers leading the study
Weiterlesen »

Britain Moves Toward Ethically Controversial COVID-19 Vaccine TrialBritain Moves Toward Ethically Controversial COVID-19 Vaccine TrialThe British government has announced plans for a coronavirus vaccine challenge trial. Volunteers will receive an experimental vaccine and be exposed to the virus to test its efficacy.
Weiterlesen »

West Virginia Covid-19 outbreaks linked to church services, governor saysWest Virginia Covid-19 outbreaks linked to church services, governor saysWest Virginia Governor Jim Justice said at least 18 active Covid-19 outbreaks were traced to church services in the state
Weiterlesen »

New Jersey’s Covid-19 Cases Rise With More Indoor GatheringsNew Jersey’s Covid-19 Cases Rise With More Indoor GatheringsIndoor gatherings in homes are fueling a new spike in coronavirus infections in New Jersey, as the number of new daily cases has roughly tripled from the figures of mid-September, health officials said
Weiterlesen »



Render Time: 2025-03-04 07:06:26